major-depressive-disorder

Documents about major-depressive-disorder

• Examination of Glutamate and mGluR5 in Psychiatric Disorders#837087ClinicalTrials.gov
• Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders#871279ClinicalTrials.gov
• Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.#839652ClinicalTrials.gov
• Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight#906082ClinicalTrials.gov
• Exploring the Role of the Prefrontal Cortex in Decision-Making#917681ClinicalTrials.gov
• Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)#1008772ClinicalTrials.gov
• Identifying transdiagnostic neurobiomarkers for precision major psychiatric disorders <i>via</i> machine learning: Causes, findings, and future directions#202229Europe PMC
• Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice#813981ClinicalTrials.gov
• Predicting weekly instability in depressive symptoms among individuals diagnosed with Major Depressive Disorder using deep learning and passively-collected movement data.#975602NCBI PubMed Central
• A Self-Rating Depression Scale#7260OpenAlex
• Structural and functional neuroimaging correlates of suicidal ideation in treatment-resistant major depressive disorder.#152134NCBI PubMed Central
• Insomnia severity impact dynamic connectivity and modulate connectivity-cognitive links in major depressive disorder.#185832NCBI PubMed Central
• Bilateral repetitive transcranial magnetic stimulation modulates the hemispheric imbalance in major depressive disorder.#269610NCBI PubMed Central
• Graph theory reveals functional connectome disruptions in adolescent major depressive disorder with childhood trauma.#334940NCBI PubMed Central
• Reproducibility of electroencephalography alpha band biomarkers for diagnosis of major depressive disorder#337069bioRxiv / medRxiv
• Aberrant neuron-OPC synaptic transmission and deficient myelination define sex bias in major depressive disorder#369706bioRxiv / medRxiv
• Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder#422384bioRxiv / medRxiv
• Frequency and E-field Enhancement of ITBS for Depression (FREED)#835439ClinicalTrials.gov
• This is a Study to Determine the Antidepressant Effects of AZD6765#838633ClinicalTrials.gov
• Mothers With a History of Depression and Their 10-14 Year Old Daughters#849606ClinicalTrials.gov
• Pharmacogenomics Studies of Antidepressants#868374ClinicalTrials.gov
• Psilocybin-assisted CBT for Depression#914232ClinicalTrials.gov
• ECT Pulse Amplitude and Medial Temporal Lobe Engagement#916131ClinicalTrials.gov
• Emotional processing biases in the longitudinal course of major depressive disorder#965864Bielefeld Pub
• Illness Severity and Longitudinal Gray Matter Volumes Among People With Major Depressive Disorder#970747Europe PMC
• Antidepressant Effects of Nitrous Oxide#995516ClinicalTrials.gov
• Characterization and correlation of gut microbiota in major depressive disorder patients with suicidal ideation.#1054012NCBI PubMed Central
• An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients#866795ClinicalTrials.gov
• RIVER At Home Ketamine Protocols#879867ClinicalTrials.gov
• Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders#905405ClinicalTrials.gov
• Depressive Disorder Among Mothers Caring for Children with Thalassemia Major in Al-Rusafa, Baghdad#427351HAL (France)
• Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study#848907ClinicalTrials.gov
• In-person vs. Remote Wellness Support#907675ClinicalTrials.gov
• Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression#844515ClinicalTrials.gov
• Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression#805783ClinicalTrials.gov
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics#811456ClinicalTrials.gov
• Individualized (fMRI-guided) TMS Treatment for Depression#836276ClinicalTrials.gov
• Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care#5416Europe PMC
• Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia#1007615ClinicalTrials.gov
• The Walla Emotion Model (WEM): A New Terminology Redefining Affective Dysregulation in Clinical Psychopathology#231305Europe PMC
• Pharmacogenetics of Antidepressant-Induced Disinhibition#810978ClinicalTrials.gov
• Reward Function and Therapy for Late-Life Depression#825857ClinicalTrials.gov
• Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression#875245ClinicalTrials.gov
• PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX#907753ClinicalTrials.gov
• Transdiagnostic iCBT for Depression and Anxiety#802052ClinicalTrials.gov
• Medication Reviews in Severe Mental Illness#879350ClinicalTrials.gov
• Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features#878896ClinicalTrials.gov
• Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression#890268ClinicalTrials.gov
• A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression#1048034ClinicalTrials.gov
• The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)#901894ClinicalTrials.gov